Genoway's change of scale fails to convince the stock market

  • Publication publiée :24 January 2024
  • Post category:Strategy / Trend
You are currently viewing Le changement d’échelle de Genoway ne convainc pas la Bourse
Alexandre Fraichard, co-founder and CEO of Genoway.

Specializing in predictive solutions for pharmaceutical research, last week the Lyon-based SME unveiled an ambitious but costly strategic plan to 2028, based on organic growth. Since then, the share price has fallen by almost 15 %. Small and mid caps are still struggling. Expected for months, or even...

...

Buy this article Choose a subscription formula

Share this article

Read also:

  1. Why the IPO market is not picking up
  2. "The stock market is not in the cognitive field of entrepreneurs"
  3. Too expensive, Deezer falls for its first steps on the stock market
  4. Start-up: and why not an IPO?
  5. Initial public offering: don't overlook HR issues
  6. Climate change: are directors up to speed?